CAJ | 학술논문

目的：探讨分析缬沙坦联合卡维地洛治疗慢性心力衰竭的临床效果及安全性。方法选取我院2013年2月～2015年2月收治的慢性心力衰竭患者100例为研究对象，随机分为2组，观察组50例，对照组50例。对照组口服缬沙坦进行治疗；观察组采用缬沙坦联合卡维地洛进行治疗，观察比较2组疗效。结果观察组（96%）总有效率比对照组（66%）多30%。2组疗效对比，差异显著（χ2=18.6896，P＜0.05）。结论缬沙坦联合卡维地洛治疗慢性心力衰竭的临床效果显著，且具有较高的安全性。
목적：탐토분석힐사탄연합잡유지락치료만성심력쇠갈적림상효과급안전성。방법선취아원2013년2월～2015년2월수치적만성심력쇠갈환자100례위연구대상，수궤분위2조，관찰조50례，대조조50례。대조조구복힐사탄진행치료；관찰조채용힐사탄연합잡유지락진행치료，관찰비교2조료효。결과관찰조（96%）총유효솔비대조조（66%）다30%。2조료효대비，차이현저（χ2=18.6896，P＜0.05）。결론힐사탄연합잡유지락치료만성심력쇠갈적림상효과현저，차구유교고적안전성。
Objective To evaluate the clinical efficacy and safety of valsartan combined with carvedilol in the treatment of chronic heart failure.Methods100 patients with chronic heart failure in our hospital from February 2013 to February 2015 were selected as the research object, randomly divided into 2 groups, observation group of 50 cases, the control group of 50 cases. Control group was treated with valsartan, observation group with combination of valsartan and carvedilol for treatment and observation of the curative effects of 2 groups were compared.Results The total effective rate of observation group (96%) was 30% more than that of control group (66%). Comparison of 2 groups, signiifcant difference (χ2=18.689 6,P<0.05).ConclusionValsartan combined with carvedilol in treatment of chronic heart failure clinical effect is remarkable.